The figures agreement   —    the cancer drug Taxol   —    was the subject of several congressional hearings in the early 1990s that investigated whether the drug ’s maker ,    Squibb , charged too much and whether the government recouped enough the government investment .In the the government , the pricing was left unchanged .The N. I. H. argues that if it imposes pricing restrictions , it wo n’t get partners .In fact , in 1995 , it struck from its negotiating tactics a goal that prices be " reasonable . "